Global Facial Aesthetics

Facial Aesthetics Comprehensive Study by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion, Hyaluronic acid), Application (Facial Line Correction Treatment, Scar Treatment, Lip Treatments, Restoration of Volume/ Fullness, Others), Product Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion), End-Use (Men, Women) Players and Region - Global Market Outlook to 2030

Facial Aesthetics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 15.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Facial Aesthetics Market Overview:
Facial aesthetics are non-surgical treatments that help in revitalizing the skin. Facial aesthetics are brisk and simple and far less expensive which is done through some devices or aesthetic implants. It’s a decent initial step for women as well as men to accept and implement a wider range of medical aesthetic services. It has additionally pulled in a huge following from patients who might never have thought about healing surgery yet are very satisfied with snappy and short-term care. Dermal fillers and botulinum toxin are used to restore the skin’s naturally youthful appearance. Non-surgical cosmetic interventions can be performed by anyone, and anyone can set up training courses. There are no guidelines regarding what constitutes adequate training or verification of courses at present. As per latest study released by AMA Research, the Global Facial Aesthetics market is expected to see growth rate of 15.7%

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
High Growth MarketAsia Pacific
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures and Increasing Demand for Aesthetic Treatments among Men

Market Growth Drivers:
Increasing Number of Clinics and Medical Spas and High Availability of Financial and Infrastructural Resources with Hospitals

Challenges:
Low Reimbursements

Restraints:
High Cost of Treatment and Risk of Malfunctions Associated Mostly With Implants

Opportunities:
The Availability of Technologically Advanced & User-Friendly Products and Technologically Advanced Devices

Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Allergan (Ireland), Solta Medical International Inc. (United States), Syneron Medical (United States), Photomedex, Inc. (United States), Cynosure (United States), Lumenis Ltd. (Israel), Johnson & Johnson (United States), Zeltiq Aesthetics (United States), Merz Pharmaceuticals GmbH (Germany), Galderma (Switzerland), Alma Lasers Ltd. (Israel), Bausch Health Companies Inc. (Canada), Merz Pharmaceuticals GmbH (Germany), Novartis AG (Switzerland) and Nestlé Skin Health (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like Anika Therapeutics Inc. (United States), Teoxane SA (Switzerland), Alpha Aesthetics (United States) and Galderma Laboratories, L.P. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Facial Aesthetics market by 2030. Considering Market by Product Type, the sub-segment i.e. Dermal Fillers will boost the Facial Aesthetics market. Considering Market by End-Use, the sub-segment i.e. Men will boost the Facial Aesthetics market.

Latest Market Insights:
In October 2023, L'Oreal and Valeant partnered on a New Injectable Filler. This partnership combines L'Oreal's expertise in skincare with Valeant's experience in developing injectable fillers. The new product, Restylane Lyft with Hyaluronic Acid Lidocaine, is expected to launch in 2024.

In September 2023, Johnson & Johnson and Galderma partnered on an AI-powered Skin Analysis Tool. This partnership aims to develop a tool that uses artificial intelligence to analyze skin health and recommend personalized treatment plans. The tool is expected to be available in dermatologists' offices and medical spas in the coming years.

Currently, there is no regulatory body or any formal process of regulation regarding the administration of non-surgical facial aesthetics. Regardless of the societal expectation that such an industry would have strict regulations and guidelines, currently, only procedures requiring surgery (i.e. those involving a surgical incision) are required to be carried out by a qualified medical professional. Botulinum toxin injections, dermal fillers, and other ‘minimally invasive’ cosmetic treatments can be administered by anyone, regardless of their qualifications.

What Can be Explored with the Facial Aesthetics Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Facial Aesthetics Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Facial Aesthetics
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Facial Aesthetics market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Facial Aesthetics market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Service Providers of Facial Aesthetics, End-Users, Manufacturers of Aesthetics Devices and Cosmetic, Healthcare Industry, Governmental Bodies, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Dermal Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion
  • Hyaluronic acid
By Application
  • Facial Line Correction Treatment
  • Scar Treatment
  • Lip Treatments
  • Restoration of Volume/ Fullness
  • Others
By Product Type
  • Dermal Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion

By End-Use
  • Men
  • Women

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Clinics and Medical Spas
      • 3.2.2. High Availability of Financial and Infrastructural Resources with Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Low Reimbursements
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
      • 3.4.2. Increasing Demand for Aesthetic Treatments among Men
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Facial Aesthetics, by Type, Application, Product Type, End-Use and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Facial Aesthetics (Value)
      • 5.2.1. Global Facial Aesthetics by: Type (Value)
        • 5.2.1.1. Dermal Fillers
        • 5.2.1.2. Botulinum Toxin
        • 5.2.1.3. Chemical Peel
        • 5.2.1.4. Microdermabrasion
        • 5.2.1.5. Hyaluronic acid
      • 5.2.2. Global Facial Aesthetics by: Application (Value)
        • 5.2.2.1. Facial Line Correction Treatment
        • 5.2.2.2. Scar Treatment
        • 5.2.2.3. Lip Treatments
        • 5.2.2.4. Restoration of Volume/ Fullness
        • 5.2.2.5. Others
      • 5.2.3. Global Facial Aesthetics by: Type (Value)
        • 5.2.3.1. Dermal Fillers
        • 5.2.3.2. Botulinum Toxin
        • 5.2.3.3. Chemical Peel
        • 5.2.3.4. Microdermabrasion
        • 5.2.3.5. Hyaluronic acid
      • 5.2.4. Global Facial Aesthetics by: Product Type (Value)
        • 5.2.4.1. Dermal Fillers
        • 5.2.4.2. Botulinum Toxin
        • 5.2.4.3. Chemical Peel
        • 5.2.4.4. Microdermabrasion
      • 5.2.5. Global Facial Aesthetics by: End-Use (Value)
        • 5.2.5.1. Men
        • 5.2.5.2. Women
      • 5.2.6. Global Facial Aesthetics Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Facial Aesthetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Solta Medical International Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Syneron Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Photomedex, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cynosure (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lumenis Ltd. (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Johnson & Johnson (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Zeltiq Aesthetics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merz Pharmaceuticals GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Galderma (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Alma Lasers Ltd. (Israel)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Bausch Health Companies Inc. (Canada)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Merz Pharmaceuticals GmbH (Germany)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Novartis AG (Switzerland)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Nestlé Skin Health (Switzerland)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Facial Aesthetics Sale, by Type, Application, Product Type, End-Use and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Facial Aesthetics (Value)
      • 7.2.1. Global Facial Aesthetics by: Type (Value)
        • 7.2.1.1. Dermal Fillers
        • 7.2.1.2. Botulinum Toxin
        • 7.2.1.3. Chemical Peel
        • 7.2.1.4. Microdermabrasion
        • 7.2.1.5. Hyaluronic acid
      • 7.2.2. Global Facial Aesthetics by: Application (Value)
        • 7.2.2.1. Facial Line Correction Treatment
        • 7.2.2.2. Scar Treatment
        • 7.2.2.3. Lip Treatments
        • 7.2.2.4. Restoration of Volume/ Fullness
        • 7.2.2.5. Others
      • 7.2.3. Global Facial Aesthetics by: Type (Value)
        • 7.2.3.1. Dermal Fillers
        • 7.2.3.2. Botulinum Toxin
        • 7.2.3.3. Chemical Peel
        • 7.2.3.4. Microdermabrasion
        • 7.2.3.5. Hyaluronic acid
      • 7.2.4. Global Facial Aesthetics by: Product Type (Value)
        • 7.2.4.1. Dermal Fillers
        • 7.2.4.2. Botulinum Toxin
        • 7.2.4.3. Chemical Peel
        • 7.2.4.4. Microdermabrasion
      • 7.2.5. Global Facial Aesthetics by: End-Use (Value)
        • 7.2.5.1. Men
        • 7.2.5.2. Women
      • 7.2.6. Global Facial Aesthetics Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Facial Aesthetics: by Type(USD Million)
  • Table 2. Facial Aesthetics Dermal Fillers , by Region USD Million (2018-2023)
  • Table 3. Facial Aesthetics Botulinum Toxin , by Region USD Million (2018-2023)
  • Table 4. Facial Aesthetics Chemical Peel , by Region USD Million (2018-2023)
  • Table 5. Facial Aesthetics Microdermabrasion , by Region USD Million (2018-2023)
  • Table 6. Facial Aesthetics Hyaluronic acid , by Region USD Million (2018-2023)
  • Table 7. Facial Aesthetics: by Application(USD Million)
  • Table 8. Facial Aesthetics Facial Line Correction Treatment , by Region USD Million (2018-2023)
  • Table 9. Facial Aesthetics Scar Treatment , by Region USD Million (2018-2023)
  • Table 10. Facial Aesthetics Lip Treatments , by Region USD Million (2018-2023)
  • Table 11. Facial Aesthetics Restoration of Volume/ Fullness , by Region USD Million (2018-2023)
  • Table 12. Facial Aesthetics Others , by Region USD Million (2018-2023)
  • Table 13. Facial Aesthetics: by Type(USD Million)
  • Table 14. Facial Aesthetics Dermal Fillers , by Region USD Million (2018-2023)
  • Table 15. Facial Aesthetics Botulinum Toxin , by Region USD Million (2018-2023)
  • Table 16. Facial Aesthetics Chemical Peel , by Region USD Million (2018-2023)
  • Table 17. Facial Aesthetics Microdermabrasion , by Region USD Million (2018-2023)
  • Table 18. Facial Aesthetics Hyaluronic acid , by Region USD Million (2018-2023)
  • Table 19. Facial Aesthetics: by Product Type(USD Million)
  • Table 20. Facial Aesthetics Dermal Fillers , by Region USD Million (2018-2023)
  • Table 21. Facial Aesthetics Botulinum Toxin , by Region USD Million (2018-2023)
  • Table 22. Facial Aesthetics Chemical Peel , by Region USD Million (2018-2023)
  • Table 23. Facial Aesthetics Microdermabrasion , by Region USD Million (2018-2023)
  • Table 24. Facial Aesthetics: by End-Use(USD Million)
  • Table 25. Facial Aesthetics Men , by Region USD Million (2018-2023)
  • Table 26. Facial Aesthetics Women , by Region USD Million (2018-2023)
  • Table 27. South America Facial Aesthetics, by Country USD Million (2018-2023)
  • Table 28. South America Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 29. South America Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 30. South America Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 31. South America Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 32. Brazil Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 33. Brazil Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 34. Brazil Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 35. Brazil Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 36. Argentina Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 37. Argentina Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 38. Argentina Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 39. Argentina Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 40. Rest of South America Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 41. Rest of South America Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 42. Rest of South America Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 43. Rest of South America Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 44. Asia Pacific Facial Aesthetics, by Country USD Million (2018-2023)
  • Table 45. Asia Pacific Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 46. Asia Pacific Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 47. Asia Pacific Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 48. Asia Pacific Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 49. China Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 50. China Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 51. China Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 52. China Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 53. Japan Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 54. Japan Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 55. Japan Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 56. Japan Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 57. India Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 58. India Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 59. India Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 60. India Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 61. South Korea Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 62. South Korea Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 63. South Korea Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 64. South Korea Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 65. Taiwan Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 66. Taiwan Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 67. Taiwan Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 68. Taiwan Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 69. Australia Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 70. Australia Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 71. Australia Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 72. Australia Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 77. Europe Facial Aesthetics, by Country USD Million (2018-2023)
  • Table 78. Europe Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 79. Europe Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 80. Europe Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 81. Europe Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 82. Germany Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 83. Germany Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 84. Germany Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 85. Germany Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 86. France Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 87. France Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 88. France Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 89. France Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 90. Italy Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 91. Italy Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 92. Italy Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 93. Italy Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 94. United Kingdom Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 95. United Kingdom Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 96. United Kingdom Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 97. United Kingdom Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 98. Netherlands Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 99. Netherlands Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 100. Netherlands Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 101. Netherlands Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 102. Rest of Europe Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 103. Rest of Europe Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 104. Rest of Europe Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 105. Rest of Europe Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 106. MEA Facial Aesthetics, by Country USD Million (2018-2023)
  • Table 107. MEA Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 108. MEA Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 109. MEA Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 110. MEA Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 111. Middle East Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 112. Middle East Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 113. Middle East Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 114. Middle East Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 115. Africa Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 116. Africa Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 117. Africa Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 118. Africa Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 119. North America Facial Aesthetics, by Country USD Million (2018-2023)
  • Table 120. North America Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 121. North America Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 122. North America Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 123. North America Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 124. United States Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 125. United States Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 126. United States Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 127. United States Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 128. Canada Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 129. Canada Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 130. Canada Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 131. Canada Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 132. Mexico Facial Aesthetics, by Type USD Million (2018-2023)
  • Table 133. Mexico Facial Aesthetics, by Application USD Million (2018-2023)
  • Table 134. Mexico Facial Aesthetics, by Product Type USD Million (2018-2023)
  • Table 135. Mexico Facial Aesthetics, by End-Use USD Million (2018-2023)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Facial Aesthetics: by Type(USD Million)
  • Table 152. Facial Aesthetics Dermal Fillers , by Region USD Million (2025-2030)
  • Table 153. Facial Aesthetics Botulinum Toxin , by Region USD Million (2025-2030)
  • Table 154. Facial Aesthetics Chemical Peel , by Region USD Million (2025-2030)
  • Table 155. Facial Aesthetics Microdermabrasion , by Region USD Million (2025-2030)
  • Table 156. Facial Aesthetics Hyaluronic acid , by Region USD Million (2025-2030)
  • Table 157. Facial Aesthetics: by Application(USD Million)
  • Table 158. Facial Aesthetics Facial Line Correction Treatment , by Region USD Million (2025-2030)
  • Table 159. Facial Aesthetics Scar Treatment , by Region USD Million (2025-2030)
  • Table 160. Facial Aesthetics Lip Treatments , by Region USD Million (2025-2030)
  • Table 161. Facial Aesthetics Restoration of Volume/ Fullness , by Region USD Million (2025-2030)
  • Table 162. Facial Aesthetics Others , by Region USD Million (2025-2030)
  • Table 163. Facial Aesthetics: by Type(USD Million)
  • Table 164. Facial Aesthetics Dermal Fillers , by Region USD Million (2025-2030)
  • Table 165. Facial Aesthetics Botulinum Toxin , by Region USD Million (2025-2030)
  • Table 166. Facial Aesthetics Chemical Peel , by Region USD Million (2025-2030)
  • Table 167. Facial Aesthetics Microdermabrasion , by Region USD Million (2025-2030)
  • Table 168. Facial Aesthetics Hyaluronic acid , by Region USD Million (2025-2030)
  • Table 169. Facial Aesthetics: by Product Type(USD Million)
  • Table 170. Facial Aesthetics Dermal Fillers , by Region USD Million (2025-2030)
  • Table 171. Facial Aesthetics Botulinum Toxin , by Region USD Million (2025-2030)
  • Table 172. Facial Aesthetics Chemical Peel , by Region USD Million (2025-2030)
  • Table 173. Facial Aesthetics Microdermabrasion , by Region USD Million (2025-2030)
  • Table 174. Facial Aesthetics: by End-Use(USD Million)
  • Table 175. Facial Aesthetics Men , by Region USD Million (2025-2030)
  • Table 176. Facial Aesthetics Women , by Region USD Million (2025-2030)
  • Table 177. South America Facial Aesthetics, by Country USD Million (2025-2030)
  • Table 178. South America Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 179. South America Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 180. South America Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 181. South America Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 182. Brazil Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 183. Brazil Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 184. Brazil Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 185. Brazil Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 186. Argentina Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 187. Argentina Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 188. Argentina Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 189. Argentina Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 190. Rest of South America Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 191. Rest of South America Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 192. Rest of South America Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 193. Rest of South America Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 194. Asia Pacific Facial Aesthetics, by Country USD Million (2025-2030)
  • Table 195. Asia Pacific Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 196. Asia Pacific Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 197. Asia Pacific Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 198. Asia Pacific Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 199. China Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 200. China Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 201. China Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 202. China Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 203. Japan Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 204. Japan Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 205. Japan Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 206. Japan Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 207. India Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 208. India Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 209. India Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 210. India Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 211. South Korea Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 212. South Korea Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 213. South Korea Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 214. South Korea Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 215. Taiwan Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 216. Taiwan Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 217. Taiwan Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 218. Taiwan Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 219. Australia Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 220. Australia Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 221. Australia Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 222. Australia Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 223. Rest of Asia-Pacific Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 224. Rest of Asia-Pacific Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 225. Rest of Asia-Pacific Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 226. Rest of Asia-Pacific Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 227. Europe Facial Aesthetics, by Country USD Million (2025-2030)
  • Table 228. Europe Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 229. Europe Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 230. Europe Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 231. Europe Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 232. Germany Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 233. Germany Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 234. Germany Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 235. Germany Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 236. France Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 237. France Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 238. France Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 239. France Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 240. Italy Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 241. Italy Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 242. Italy Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 243. Italy Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 244. United Kingdom Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 245. United Kingdom Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 246. United Kingdom Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 247. United Kingdom Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 248. Netherlands Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 249. Netherlands Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 250. Netherlands Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 251. Netherlands Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 252. Rest of Europe Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 253. Rest of Europe Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 254. Rest of Europe Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 255. Rest of Europe Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 256. MEA Facial Aesthetics, by Country USD Million (2025-2030)
  • Table 257. MEA Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 258. MEA Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 259. MEA Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 260. MEA Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 261. Middle East Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 262. Middle East Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 263. Middle East Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 264. Middle East Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 265. Africa Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 266. Africa Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 267. Africa Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 268. Africa Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 269. North America Facial Aesthetics, by Country USD Million (2025-2030)
  • Table 270. North America Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 271. North America Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 272. North America Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 273. North America Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 274. United States Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 275. United States Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 276. United States Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 277. United States Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 278. Canada Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 279. Canada Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 280. Canada Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 281. Canada Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 282. Mexico Facial Aesthetics, by Type USD Million (2025-2030)
  • Table 283. Mexico Facial Aesthetics, by Application USD Million (2025-2030)
  • Table 284. Mexico Facial Aesthetics, by Product Type USD Million (2025-2030)
  • Table 285. Mexico Facial Aesthetics, by End-Use USD Million (2025-2030)
  • Table 286. Research Programs/Design for This Report
  • Table 287. Key Data Information from Secondary Sources
  • Table 288. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Facial Aesthetics: by Type USD Million (2018-2023)
  • Figure 5. Global Facial Aesthetics: by Application USD Million (2018-2023)
  • Figure 6. Global Facial Aesthetics: by Type USD Million (2018-2023)
  • Figure 7. Global Facial Aesthetics: by Product Type USD Million (2018-2023)
  • Figure 8. Global Facial Aesthetics: by End-Use USD Million (2018-2023)
  • Figure 9. South America Facial Aesthetics Share (%), by Country
  • Figure 10. Asia Pacific Facial Aesthetics Share (%), by Country
  • Figure 11. Europe Facial Aesthetics Share (%), by Country
  • Figure 12. MEA Facial Aesthetics Share (%), by Country
  • Figure 13. North America Facial Aesthetics Share (%), by Country
  • Figure 14. Global Facial Aesthetics share by Players 2023 (%)
  • Figure 15. Global Facial Aesthetics share by Players (Top 3) 2023(%)
  • Figure 16. Global Facial Aesthetics share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Allergan (Ireland) Revenue: by Geography 2023
  • Figure 20. Solta Medical International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Solta Medical International Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Syneron Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Syneron Medical (United States) Revenue: by Geography 2023
  • Figure 24. Photomedex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Photomedex, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Cynosure (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cynosure (United States) Revenue: by Geography 2023
  • Figure 28. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 29. Lumenis Ltd. (Israel) Revenue: by Geography 2023
  • Figure 30. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 31. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 32. Zeltiq Aesthetics (United States) Revenue, Net Income and Gross profit
  • Figure 33. Zeltiq Aesthetics (United States) Revenue: by Geography 2023
  • Figure 34. Merz Pharmaceuticals GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Merz Pharmaceuticals GmbH (Germany) Revenue: by Geography 2023
  • Figure 36. Galderma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Galderma (Switzerland) Revenue: by Geography 2023
  • Figure 38. Alma Lasers Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 39. Alma Lasers Ltd. (Israel) Revenue: by Geography 2023
  • Figure 40. Bausch Health Companies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 41. Bausch Health Companies Inc. (Canada) Revenue: by Geography 2023
  • Figure 42. Merz Pharmaceuticals GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 43. Merz Pharmaceuticals GmbH (Germany) Revenue: by Geography 2023
  • Figure 44. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 45. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 46. Nestlé Skin Health (Switzerland) Revenue, Net Income and Gross profit
  • Figure 47. Nestlé Skin Health (Switzerland) Revenue: by Geography 2023
  • Figure 48. Global Facial Aesthetics: by Type USD Million (2025-2030)
  • Figure 49. Global Facial Aesthetics: by Application USD Million (2025-2030)
  • Figure 50. Global Facial Aesthetics: by Type USD Million (2025-2030)
  • Figure 51. Global Facial Aesthetics: by Product Type USD Million (2025-2030)
  • Figure 52. Global Facial Aesthetics: by End-Use USD Million (2025-2030)
  • Figure 53. South America Facial Aesthetics Share (%), by Country
  • Figure 54. Asia Pacific Facial Aesthetics Share (%), by Country
  • Figure 55. Europe Facial Aesthetics Share (%), by Country
  • Figure 56. MEA Facial Aesthetics Share (%), by Country
  • Figure 57. North America Facial Aesthetics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergan (Ireland)
  • Solta Medical International Inc. (United States)
  • Syneron Medical (United States)
  • Photomedex, Inc. (United States)
  • Cynosure (United States)
  • Lumenis Ltd. (Israel)
  • Johnson & Johnson (United States)
  • Zeltiq Aesthetics (United States)
  • Merz Pharmaceuticals GmbH (Germany)
  • Galderma (Switzerland)
  • Alma Lasers Ltd. (Israel)
  • Bausch Health Companies Inc. (Canada)
  • Merz Pharmaceuticals GmbH (Germany)
  • Novartis AG (Switzerland)
  • Nestlé Skin Health (Switzerland)
Additional players considered in the study are as follows:
Anika Therapeutics Inc. (United States) , Teoxane SA (Switzerland) , Alpha Aesthetics (United States) , Galderma Laboratories, L.P. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 189 Pages 84 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Facial Aesthetics Quantitative research analysis
Global Facial Aesthetics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Facial Aesthetics market are Allergan (Ireland), Solta Medical International Inc. (United States), Syneron Medical (United States), Photomedex, Inc. (United States), Cynosure (United States), Lumenis Ltd. (Israel), Johnson & Johnson (United States), Zeltiq Aesthetics (United States), Merz Pharmaceuticals GmbH (Germany), Galderma (Switzerland), Alma Lasers Ltd. (Israel), Bausch Health Companies Inc. (Canada), Merz Pharmaceuticals GmbH (Germany), Novartis AG (Switzerland) and Nestlé Skin Health (Switzerland), to name a few.
"Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures " is seen as one of major influencing trends for Facial Aesthetics Market during projected period 2023-2030.
Dermal Fillers segment in Global market to hold robust market share owing to "Increasing Number of Clinics and Medical Spas ".
Hyaluronic acid dominated the Facial Aesthetics market. This is attributable to growing trend of "Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures "

Know More About Global Facial Aesthetics Report?

Have a Query? Click Here

Other Related Reports

Basal Cell Carcinoma Treatment Comprehensive Study by Application (Hospitals, Specialty Clinics, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4), Treatment Type (Surgery {Surgical Excis...
$ 3750
Pulmonary Drug Delivery Systems Comprehensive Study by Type (Metered Dose Inhalers (Manually-Actuated Pressurized Inhaler, Breath-Actuated Pressurized Inhaler), Dry Powder Inhalers (Single-Dose Inhal...
$ 3750
Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessori...
$ 3750
Syphilis Testing Comprehensive Study by Type (Treponemal tests, Non-treponemal tests), Syphilis types (Primary Syphilis, Secondary Syphilis, Others (Latent (hidden) stage, Tertiary (late) stage)), G...
$ 3450
Bioactive Wound Management Comprehensive Study by Type (Moist Wound Care, Antimicrobial Wound Care, Others), Application (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Bu...
$ 3750
Ophthalmological Ultrasound Systems Comprehensive Study by Type (A- Scan, B- Scan, Combined Scan, Pachymeter, Ultrasound Bio-microscopy (UBM)), Modality (Portable, Standalone), End User (Hospitals, O...
$ 3350